type here...

CATEGORIES

Breaking Research

LATEST

1234Page 4 of 4

TRENDING

EDITORS CHOICE

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

Researchers Have Stepped Into the Weird World of Science Fiction

Pat Farrell PhD -
Curing disease, growing organs, and even teaching organoids to play a computer game are sending seismic waves of hope within the research community as the potential increases exponentially.

How COVID and the Power of Now Killed Scientific Peer Review

Gil Bashe, Medika Life Editor -
How long do or should clinical trials take – well, it depends – but often years. Science takes time. It demands rigor and objectivity. It’s not a “now” pursuit.

AI in Public Health: Revolution, Risk and Opportunity

Christopher Nial -
ntroduction Artificial Intelligence (AI) is rapidly reshaping public health — from enhancing disease surveillance and diagnostics to easing workforce burdens — but it also raises...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories